These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 28552652)

  • 1. Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey.
    Grenier J; Goodman SG; Leiter LA; Langer A; Teoh H; Bhatt DL; Cheng AYY; Tan MK; Ransom T; Connelly KA; Yan AT
    Can J Diabetes; 2018 Apr; 42(2):130-137. PubMed ID: 28552652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey.
    Grenier J; Leiter LA; Langer A; Goldin L; Teoh H; Connelly KA; Cheng AYY; Tan MK; Fitchett D; McGuire DK; Goodman SG; Yan AT
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):277-284. PubMed ID: 29474711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal Blood Pressure Control, Associated Factors, and Choice of Antihypertensive Drugs among Type 2 Diabetic Patients at KCMC, Tanzania.
    Mbwete GW; Kilonzo KG; Shao ER; Chamba NG
    J Diabetes Res; 2020; 2020():4376251. PubMed ID: 32775461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difficulties in reaching therapeutic goals for hypertension and dysplipidaemia in patients with type 2 diabetes in general practice.
    Knudsen ST; Mosbech TH; Hansen B; Kønig E; Johnsen PC; Kamper AL
    Dan Med J; 2013 Dec; 60(12):A4740. PubMed ID: 24355449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of risk factors among ambulatory patients at high cardiovascular risk in Canada: a follow-up study.
    Elbarasi EA; Goodman SG; Yan RT; Tan MK; Hackam DG; Leiter LA; Langer A; Yan AT;
    Can J Cardiol; 2013 Dec; 29(12):1586-92. PubMed ID: 24041994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure treatment levels and choice of antihypertensive agent in people with diabetes mellitus: an overview of systematic reviews.
    Brunström M; Eliasson M; Nilsson PM; Carlberg B
    J Hypertens; 2017 Mar; 35(3):453-462. PubMed ID: 27870655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in blood pressure control in hypertensive patients with diabetes mellitus in Japan.
    Hirose H; Saito I
    Hypertens Res; 2003 Sep; 26(9):717-22. PubMed ID: 14620927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of 5413 hypertensive patients: a cross-sectional study.
    Paulsen MS; Sondergaard J; Reuther L; Larsen PS; Munck AP; Larsen PV; Damsgaard J; Poulsen L; Hansen DG; Jacobsen IA; Larsen ML; Christensen HR; Christensen B; Andersen M
    Fam Pract; 2011 Dec; 28(6):599-607. PubMed ID: 21596691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide assessment of blood pressure control and the associated factors in Chinese type 2 diabetes mellitus patients.
    Zhang YQ; Li Y; Dong YG; Wu YH; Bian R; Li JH; Ji LN
    J Clin Hypertens (Greenwich); 2019 Nov; 21(11):1654-1663. PubMed ID: 31603618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment gaps for hypertension management in rural Canadian patients with type 2 diabetes mellitus.
    Supina AL; Guirguis LM; Majumdar SR; Lewanczuk RZ; Lee TK; Toth EL; Johnson JA
    Clin Ther; 2004 Apr; 26(4):598-606. PubMed ID: 15189757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of hypertension in Switzerland. The 2009 Swiss Hypertension Survey (SWISSHYPE).
    Brenner R; Waeber B; Allemann Y
    Swiss Med Wkly; 2011; 141():w13169. PubMed ID: 21374529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.
    Braga M; Casanova A; Teoh H; Dawson KC; Gerstein HC; Fitchett DH; Harris SB; Honos G; McFarlane PA; Steele A; Ur E; Yale JF; Langer A; Goodman SG; Leiter LA;
    Can J Cardiol; 2010; 26(6):297-302. PubMed ID: 20548975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.